Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

McGill University

$40,000.00

Toward the accurate prediction of P450-mediated metabolism and adverse drug reactions using novel MM methods and QM-derived rules

EF 2013-14

Résumé
Despite the large investment in toxicology and clinical trials of drug candidates, toxicity of drugsremains a leading cause of drug failure or even drug withdrawal. Over the years, medicinal chemists have relied on ""structural alerts"" to identify potential toxicity of drugs. These functional groups are oftenactivated by metabolic enzymes (e.g., P450) into reactive metabolites leading to the observed toxicity.However the presence of such a functional group does not always correlate with toxicity as the bioactivationcan only occur if the drug is processed (i.e., recognized) by these enzymes and, although widely used, thisapproach is not reliable (C&EN 2012, 90, 34). Thus, computational prediction has become an avenue ofresearch and in this context we have developed a program, IMPACTS (AstraZeneca/NSERC CRD funding01/2010-02/2012) which predicts the site of metabolism of drugs, hence whether the drug and structural alertcan be processed by the major P450s. This program combines ligand reactivity rules (which sites of the drugare the most reactive?), docking (how does the drug bind in the catalytic site of enzymes?) and molecularmechanics (what is the energy of activation for a given site) to predict the most likely site of metabolism.This program relies on energies of activation pre-computed by density functional theory (DFT) and potential energy computed by a force field. In a partnership with Chemical Computing Group, we will further develop and improve this program in two ways. First, we propose to use quantum mechanical techniques (ie, DFT) to improve the ligand reactivity rules and more specifically their inclination to lead to reactive metabolites once bioactivated by P450s. Second we propose to develop a conceptually novel force field to compute drug potential energies more accurately.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
441810-2012
Name nom
Moitessier, Nicolas
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
40000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3156
Research subject group en
Theoretical physics and chemistry
Research subject group fr
Physique et chimie théoriques
Research subject en
Quantum and/or computational chemistry
Research subject fr
Chimie quantique ou par modélisation numérique
Partie
1
Nb partie
1
Application title
Toward the accurate prediction of P450-mediated metabolism and adverse drug reactions using novel MM methods and QM-derived rules
Keyword
NSERC
Application summary
Despite the large investment in toxicology and clinical trials of drug candidates, toxicity of drugsremains a leading cause of drug failure or even drug withdrawal. Over the years, medicinal chemists have relied on ""structural alerts"" to identify potential toxicity of drugs. These functional groups are oftenactivated by metabolic enzymes (e.g., P450) into reactive metabolites leading to the observed toxicity.However the presence of such a functional group does not always correlate with toxicity as the bioactivationcan only occur if the drug is processed (i.e., recognized) by these enzymes and, although widely used, thisapproach is not reliable (C&EN 2012, 90, 34). Thus, computational prediction has become an avenue ofresearch and in this context we have developed a program, IMPACTS (AstraZeneca/NSERC CRD funding01/2010-02/2012) which predicts the site of metabolism of drugs, hence whether the drug and structural alertcan be processed by the major P450s. This program combines ligand reactivity rules (which sites of the drugare the most reactive?), docking (how does the drug bind in the catalytic site of enzymes?) and molecularmechanics (what is the energy of activation for a given site) to predict the most likely site of metabolism.This program relies on energies of activation pre-computed by density functional theory (DFT) and potential energy computed by a force field. In a partnership with Chemical Computing Group, we will further develop and improve this program in two ways. First, we propose to use quantum mechanical techniques (ie, DFT) to improve the ligand reactivity rules and more specifically their inclination to lead to reactive metabolites once bioactivated by P450s. Second we propose to develop a conceptually novel force field to compute drug potential energies more accurately.